Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL CANNABIS TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL CANNABIS TESTING MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL CANNABIS TESTING MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 REGULATORY SCENARIO
6 PREMIUM INSIGHTS
7 INDUSTRY INSIGHTS
8 IMPACT OF COVID-19 PANDEMIC ON THE MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 CONCLUSION
9 REGULATORY SCENARIO
10 GLOBAL CANNABIS TESTING MARKET, BY TYPE
10.1 OVERVIEW
10.2 PRODUCT & SOFTWARE
10.2.1 TESTING PRODUCT
10.2.1.1. ANALYTICAL INSTRUMENTS
10.2.1.2. CHROMATOGRAPHY INSTRUMENTS
10.2.1.2.1. LIQUID CHROMATOGRAPHY
10.2.1.2.2. GAS CHROMATOGRAPHY
10.2.1.2.3. OTHERS
10.2.1.3. SPECTROSCOPY INSTRUMENTS
10.2.1.3.1. MASS SPECTROMETRY INSTRUMENTS
10.2.1.3.2. ATOMIC SPECTROSCOPY INSTRUMENTS
10.2.1.4. OTHERS
10.2.1.5. CONSUMABLES
10.2.1.5.1. COLUMNS
10.2.1.5.2. REFERENCE STANDARDS
10.2.1.5.3. SAMPLE HANDLING PRODUCTS
10.2.1.5.4. SUPPLIES & ACCESSORIES
10.2.2 TESTING SOFTWARE
10.3 SERVICES
10.3.1 POTENCY TESTING
10.3.2 TERPENE PROFILING
10.3.3 RESIDUAL SOLVENT ANALYSIS
10.3.4 MICROBIAL ANALYSIS
10.3.5 PESTICIDE SCREENING
10.3.6 HEAVY METAL TESTING
10.3.7 OTHERS
11 GLOBAL CANNABIS TESTING MARKET, BY MEDICINAL APPLICATION
11.1 OVERVIEW
11.2 ALZHEIMER'S DISEASE
11.3 APPETITE LOSS
11.4 CANCER
11.5 INFLAMMATORY BOWEL DISEASES
11.6 EATING DISORDERS
11.7 EPILEPSY
11.8 AUTISM
11.9 MENTAL HEALTH CONDITIONS
11.9.1 SCHIZOPHRENIA
11.9.2 POSTTRAUMATIC STRESS DISORDER (PTSD)
11.9.3 OTHERS
11.1 MULTIPLE SCLEROSIS
11.11 PAIN MANAGEMENT
11.11.1 CHRONIC PAIN
11.11.2 NEUROLOGICAL PAIN
11.11.3 NON-CANCER CHRONIC PAIN
11.12 NAUSEA
11.13 MUSCLE SPASMS
11.14 WASTING SYNDROME (CACHEXIA)
11.15 ELEVATE MOOD
11.16 DEPRESSION AND SLEEP DISORDERS
11.17 ANXIETY
11.18 OTHERS
12 GLOBAL CANNABIS TESTING MARKET, BY END USER
12.1 OVERVIEW
12.2 CANNABIS TESTING LABORATORIES
12.2.1 SMALL-SCALE LABORATORIES
12.2.2 MEDIUM-SCALE LABORATORIES
12.2.3 LARGE-SCALE LABORATORIES
12.3 RESEARCH INSTITUTES
12.4 CANNABIS DRUG MANUFACTURERS
12.5 CANNABIS DRUG DISPENSARIES
12.6 CANNABIS CULTIVATORS/GROWERS
13 GLOBAL CANNABIS TESTING MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 THIRD PARTY DISTRIBUTORS
13.4 OTHERS
14 GLOBAL CANNABIS TESTING MARKET, BY REGION
GLOBAL CANNABIS TESTING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
14.2 EUROPE
14.2.1 GERMANY
14.2.2 FRANCE
14.2.3 U.K.
14.2.4 ITALY
14.2.5 SPAIN
14.2.6 RUSSIA
14.2.7 TURKEY
14.2.8 BELGIUM
14.2.9 NETHERLANDS
14.2.10 SWITZERLAND
14.2.11 REST OF EUROPE
14.3 ASIA-PACIFIC
14.3.1 JAPAN
14.3.2 CHINA
14.3.3 SOUTH KOREA
14.3.4 INDIA
14.3.5 AUSTRALIA
14.3.6 SINGAPORE
14.3.7 THAILAND
14.3.8 MALAYSIA
14.3.9 INDONESIA
14.3.10 PHILIPPINES
14.3.11 REST OF ASIA-PACIFIC
14.4 SOUTH AMERICA
14.4.1 BRAZIL
14.4.2 ARGENTINA
14.4.3 REST OF SOUTH AMERICA
14.5 MIDDLE EAST AND AFRICA
14.5.1 SOUTH AFRICA
14.5.2 SAUDI ARABIA
14.5.3 UAE
14.5.4 EGYPT
14.5.5 ISRAEL
14.5.6 REST OF MIDDLE EAST AND AFRICA
14.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
15 GLOBAL CANNABIS TESTING MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3 COMPANY SHARE ANALYSIS: EUROPE
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15.5 MERGERS & ACQUISITIONS
15.6 NEW PRODUCT DEVELOPMENT & APPROVALS
15.7 EXPANSIONS
15.8 REGULATORY CHANGES
15.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
16 GLOBAL CANNABIS TESTING MARKET, SWOT AND DBMR ANALYSIS
17 GLOBAL CANNABIS TESTING MARKET, COMPANY PROFILE
17.1 AGILENT TECHNOLOGIES, INC.
17.1.1 COMPANY OVERVIEW
17.1.2 REVENUE ANALYSIS
17.1.3 GEOGRAPHIC PRESENCE
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 SHIMADZU CORPORATION
17.2.1 COMPANY OVERVIEW
17.2.2 REVENUE ANALYSIS
17.2.3 GEOGRAPHIC PRESENCE
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 MERCK KGAA
17.3.1 COMPANY OVERVIEW
17.3.2 REVENUE ANALYSIS
17.3.3 GEOGRAPHIC PRESENCE
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 THERMO FISHER SCIENTIFIC
17.4.1 COMPANY OVERVIEW
17.4.2 REVENUE ANALYSIS
17.4.3 GEOGRAPHIC PRESENCE
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 DIGIPATH, INC.
17.5.1 COMPANY OVERVIEW
17.5.2 REVENUE ANALYSIS
17.5.3 GEOGRAPHIC PRESENCE
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 STEEP HILL INC.
17.6.1 COMPANY OVERVIEW
17.6.2 REVENUE ANALYSIS
17.6.3 GEOGRAPHIC PRESENCE
17.6.4 PRODUCT PORTFOLIO
17.6.5 RECENT DEVELOPMENTS
17.7 SC LABORATORIES, INC.
17.7.1 COMPANY OVERVIEW
17.7.2 REVENUE ANALYSIS
17.7.3 GEOGRAPHIC PRESENCE
17.7.4 PRODUCT PORTFOLIO
17.7.5 RECENT DEVELOPMENTS
17.8 PHARMLABS LLC
17.8.1 COMPANY OVERVIEW
17.8.2 REVENUE ANALYSIS
17.8.3 GEOGRAPHIC PRESENCE
17.8.4 PRODUCT PORTFOLIO
17.8.5 RECENT DEVELOPMENTS
17.9 RESTEK CORPORATION
17.9.1 COMPANY OVERVIEW
17.9.2 REVENUE ANALYSIS
17.9.3 GEOGRAPHIC PRESENCE
17.9.4 PRODUCT PORTFOLIO
17.9.5 RECENT DEVELOPMENTS
17.1 PERKINELMER INC.
17.10.1 COMPANY OVERVIEW
17.10.2 REVENUE ANALYSIS
17.10.3 GEOGRAPHIC PRESENCE
17.10.4 PRODUCT PORTFOLIO
17.10.5 RECENT DEVELOPMENTS
17.11 ACCELERATED TECHNOLOGY LABORATORIES, INC
17.11.1 COMPANY OVERVIEW
17.11.2 REVENUE ANALYSIS
17.11.3 GEOGRAPHIC PRESENCE
17.11.4 PRODUCT PORTFOLIO
17.11.5 RECENT DEVELOPMENTS
17.12 CANNASAFE ANALYTICS
17.12.1 COMPANY OVERVIEW
17.12.2 REVENUE ANALYSIS
17.12.3 GEOGRAPHIC PRESENCE
17.12.4 PRODUCT PORTFOLIO
17.12.5 RECENT DEVELOPMENTS
17.13 ANANDIA LABS
17.13.1 COMPANY OVERVIEW
17.13.2 REVENUE ANALYSIS
17.13.3 GEOGRAPHIC PRESENCE
17.13.4 PRODUCT PORTFOLIO
17.13.5 RECENT DEVELOPMENTS
17.14 EIRLAB RESEARCH GROUP
17.14.1 COMPANY OVERVIEW
17.14.2 REVENUE ANALYSIS
17.14.3 GEOGRAPHIC PRESENCE
17.14.4 PRODUCT PORTFOLIO
17.14.5 RECENT DEVELOPMENTS
17.15 PHYTOVISTA LABORATORIES
17.15.1 COMPANY OVERVIEW
17.15.2 REVENUE ANALYSIS
17.15.3 GEOGRAPHIC PRESENCE
17.15.4 PRODUCT PORTFOLIO
17.15.5 RECENT DEVELOPMENTS
17.16 PURE ANALYTICS LLC
17.16.1 COMPANY OVERVIEW
17.16.2 REVENUE ANALYSIS
17.16.3 GEOGRAPHIC PRESENCE
17.16.4 PRODUCT PORTFOLIO
17.16.5 RECENT DEVELOPMENTS
17.17 MM ENTERPRISES USA, LLC
17.17.1 COMPANY OVERVIEW
17.17.2 REVENUE ANALYSIS
17.17.3 GEOGRAPHIC PRESENCE
17.17.4 PRODUCT PORTFOLIO
17.17.5 RECENT DEVELOPMENTS
17.18 TERRA TECH CORP.
17.18.1 COMPANY OVERVIEW
17.18.2 REVENUE ANALYSIS
17.18.3 GEOGRAPHIC PRESENCE
17.18.4 PRODUCT PORTFOLIO
17.18.5 RECENT DEVELOPMENTS
17.19 APHRIA INC
17.19.1 COMPANY OVERVIEW
17.19.2 REVENUE ANALYSIS
17.19.3 GEOGRAPHIC PRESENCE
17.19.4 PRODUCT PORTFOLIO
17.19.5 RECENT DEVELOPMENTS
17.2 WATERS CORPORATION
17.20.1 COMPANY OVERVIEW
17.20.2 REVENUE ANALYSIS
17.20.3 GEOGRAPHIC PRESENCE
17.20.4 PRODUCT PORTFOLIO
17.20.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
18 RELATED REPORTS
19 CONSCLUSION
20 QUESTIONNAIRE
21 ABOUT DATA BRIDGE MARKET RESEARCH
